In vivo imaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice

Experimental Dermatology

Volumn 22, Issue 2, 2013, Pages 137-140

  El Jamal, Noura ^a,b   Dubuquoy, Laurent ^a,b   Auwerx, Johan ^c,e   Bertin, Benjamin ^a,b   Desreumaux, Pierre ^a,b,d  

^a UNIVERSITÉ DE LILLE   (France)

^b UNIV LILLE   (France)

^c INSTITUT CLINIQUE DE LA SOURIS   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e EPFL   (Switzerland)

Author keywords

Bioluminescence; Luciferase; Peroxisome proliferator activated receptor; Transgenic mice

Indexed keywords

LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVITY; FLUORESCENCE IMAGING; GENE CONTROL; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTON EMISSION TOMOGRAPHY; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASE; TRANSCRIPTION INITIATION;

ANIMALS; FIREFLY LUCIFERIN; GENES, REPORTER; LUCIFERASES; LUMINESCENCE; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY; PHOTONS; PPAR ALPHA; PPAR GAMMA; PROTEIN ISOFORMS; PYRIMIDINES; RESPONSE ELEMENTS; SKIN; THIAZOLIDINEDIONES;

EID: 84873143701     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12082     Document Type: Article

References (31)

1. Zoete V, Grosdidier A, Michielin O. Biochim Biophys Acta 2007: 1771: 915-925.
2. Clark R B. J Leukoc Biol 2002: 71: 388-400.
3. Daynes R A, Jones D C. Nat Rev Immunol 2002: 2: 748-759.
4. Belvisi M G, Mitchell J A. Br J Pharmacol 2009: 158: 994-1003.
5. Friedmann P S, Cooper H L, Healy E. Acta Derm Venereol 2005: 85: 194-202.
6. Kuenzli S, Saurat J H. Br J Dermatol 2003: 149: 229-236.
7. Sertznig P, Reichrath J. Dermatoendocrinol 2011: 3: 130-135.
8. Sugawara T, Nemoto K, Adachi Y et al. Exp Dermatol 2012: 21: 543-546.
9. Kim J K, Mun S, Kim M S et al. Exp Dermatol 2012: 21: 211-216.
10. Jiang Y J, Kim P, Lu Y F et al. Exp Dermatol 2011: 20: 595-599.
11. Plager D A, Leontovich A A, Henke S A et al. Exp Dermatol 2007: 16: 28-36.
12. Ellis C N, Varani J, Fisher G J et al. Arch Dermatol 2000: 136: 609-616.
13. Robertshaw H, Friedmann P S. Br J Dermatol 2005: 152: 189-191.
14. Malhotra A, Shafiq N, Rajagopalan S et al. Evid Based Med 2012: 17: 171-176.
15. Jung K, Tanaka A, Fujita H et al. J Allergy Clin Immunol 2011: 127: 420-429. e1-6.
16. Sertznig P, Seifert M, Tilgen W et al. J Cell Physiol 2007: 212: 1-12.
17. Hanley K, Jiang Y, He S S et al. J Invest Dermatol 1998: 110: 368-375.
18. Mossner R, Meyer P, Jankowski F et al. Cancer Lett 2007: 246: 218-223.
19. Kopelovich L, Fay J R, Glazer R I et al. Mol Cancer Ther 2002: 1: 357-363.
20. Pirat C, Farce A, Lebegue N et al. J Med Chem 2012: 55: 4027-4061.
21. Maggi A, Ciana P. Nat Rev Drug Discov 2005: 4: 249-255.
22. Lucignani G, Ottobrini L, Martelli C et al. Trends Biotechnol 2006: 24: 410-418.
23. Ravnskjaer K, Frigerio F, Boergesen M et al. J Lipid Res 2010: 51: 1370-1379.
24. Ramachandran B, Stell A, Maravigna L et al. Endocr Relat Cancer 2011: 18: R41-R51.
25. Ottobrini L, Ciana P, Biserni A et al. Mol Cell Endocrinol 2006: 246: 69-75.
26. Biserni A, Giannessi F, Sciarroni A F et al. Mol Pharmacol 2008: 73: 1434-1443.
27. Ciana P, Biserni A, Tatangelo L et al. Mol Endocrinol 2007: 21: 388-400.
28. Nebbioso A, Dell'Aversana C, Bugge A et al. J Mol Endocrinol 2010: 45: 219-228.
29. Welch J S, Ricote M, Akiyama T E et al. Proc Natl Acad Sci USA 2003: 100: 6712-6717.
30. Sahu R P, DaSilva S C, Rashid B et al. Int J Cancer 2012: 131: E1055-E1066.
31. Maggi A, Rando G. Methods Mol Biol 2009: 590: 307-316.